Display Settings:

Format

Send to:

Choose Destination

    Chem Biol. 2007 Dec;14(12):1309-11.

    2-AG + 2 new players = forecast for therapeutic advances.

    Marrs W, Stella N.

    Graduate Program in Neurobiology and Behavior, University of Washington, Seattle, WA 98195, USA.

    Comment on:

    In this issue of Chemistry & Biology, Blankman et al. identify new enzymes hydrolyzing the endocannabionoid 2-arachidonoyl glycerol (2-AG), increasing the complexity of endocannabinoid signaling in the brain, but also pinpointing additional therapeutic targets.

    PMID: 18096497 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read